Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-26
2005-04-26
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S139000, C546S184000, C546S210000, C548S314700, C548S349100, C548S351100, C514S326000, C514S399000
Reexamination Certificate
active
06884801
ABSTRACT:
Compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof are disclosed. Such compounds are useful in the treatment of Alpha-1A mediated diseases or conditions such as urinary incontinence.
REFERENCES:
patent: 3754002 (1973-08-01), Brown et al.
patent: 4506074 (1985-03-01), Huff et al.
patent: 0 887 346 (1998-12-01), None
Hodson et al (2002): J. Med. Chem, vol 45, 2229-2239.*
Saari, Walfred S., J. Med. Chem., (1983), 26, 1769-72.
Bigham Eric Cleveland
Bishop Michael Joseph
Drewry David Harold
Garrison Deanna Trojan
Hodson Stephen Joseph
Brink Robert H.
Shameem Golam M M
SmithKline Beecham Corporation
LandOfFree
Imidazoline derivatives as alpha-1A adrenoceptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoline derivatives as alpha-1A adrenoceptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoline derivatives as alpha-1A adrenoceptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3409896